Affiliation:
1. Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
Abstract
Background:
The present article is related to in-vitro and in-vivo herb-drug interaction studies.
Objectives:
This study aimed to investigate the effect of Nigella sativa and fenugreek on the pharmacodynamics and
pharmacokinetics of amlodipine.
Method:
Hypertensive rats of group-I were treated with amlodipine and rats of group-II and III were treated with N.
sativa, and N. sativa + amlodipine and fenugreek, and fenugreek + amlodipine, respectively. Systolic blood pressure
(SBP), diastolic blood pressure (DBP) and mean blood pressure (MBP) of group-I, II and III rats were measured by
the “tail-cuff system”.
Results:
N. sativa, as well as fenugreek, reduced the SBP, DBP and MBP. Simultaneously, administration of
fenugreek + amlodipine or N. sativa + amlodipine showed better control of BP. Individually, fenugreek, as well as N.
sativa, showed a surprising reduction in the heart rate. There was no remarkable effect of any of these two herbs on
Cmax, AUC0-t, Kel, and terminal elimination half-life of amlodipine, but fenugreek altered the Tmax of amlodipine
significantly, from 2 ± 1.2h in control to 7.2 ± 1.7h in fenugreek treated group, probably by delaying the absorption.
Conclusion:
Results of pharmacodynamics and pharmacokinetics studies suggested that simultaneous administration
of fenugreek or N. sativa with amlodipine improved the pharmacological response of amlodipine in hypertensive rats,
though there was no remarkable change in pharmacokinetic parameters (Cmax, Kel, elimination t1/2, and AUC0-t).
Funder
Deanship of Scientific Research at King Saud University, Saudi Arab
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Pharmacology
Reference40 articles.
1. Volpe M.; Gallo G.; Tocci G.; . New approach to blood pressure control: Triple combination pill. Trends. Cardiovasc Med, 2019,,pii,S1050-1738(19)30031-3.
2. Salam A.; Atkins E.R.; Hsu B.; Webster R.; Patel A.; Rodgers A.; Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 2019,37(8),1567-1573
3. Lu P.P.; Meng X.; Zhang Y.; Li Y.Q.; Wang S.; Liu L.S.; Wang W.; Li Y.L.; Zhang Y.Q.; Hu A.H.; Zhou X.L.; Ma L.H.; Twenty-four-hour ambulatory blood pressure changes in older patients with essential hypertension receiving monotherapy or dual combination antihypertensive drug therapy. J Geriatr Cardiol 2019,16(4),354-361
4. Simon A.; Dézsi C.A.; Treatment of Hypertensive and hypercholesterolaemic patients with the triple fixed combination of atorvastatin, perindopril and amlodipine: The results of the CORAL study. Adv Ther 2019,36(8),2010-2020
5. Alkaabi M.S.; Rabbani S.A.; Rao P.G.M.; Ali S.R.; Prescription pattern of antihypertensive drugs: An experience from a secondary care hospital in the United Arab Emirates. J Res Pharm Pract 2019,8(2),92-100
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献